Fulcrum Therapeutics, Inc. (FULC)
3.855
0.00 (0.00%)
USD |
NASDAQ |
Aug 28, 16:00
3.855
0.00 (0.00%)
After-Hours: 18:51
Fulcrum Therapeutics Price : 3.855 for Aug. 28, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 27, 2026 | 3.86 | 3.89 | 3.825 | 3.85 | 785024.0 |
| Aug 26, 2026 | 3.86 | 3.88 | 3.82 | 3.86 | 854863.0 |
| Aug 25, 2026 | 3.87 | 3.89 | 3.835 | 3.86 | 1.320M |
| Aug 24, 2026 | 3.835 | 3.86 | 3.78 | 3.84 | 856383.0 |
| Aug 21, 2026 | 3.85 | 3.90 | 3.78 | 3.83 | 1.513M |
| Aug 20, 2026 | 3.88 | 3.907 | 3.81 | 3.85 | 1.198M |
| Aug 19, 2026 | 3.90 | 3.94 | 3.855 | 3.91 | 2.179M |
| Aug 18, 2026 | 3.85 | 3.90 | 3.745 | 3.87 | 2.751M |
| Aug 17, 2026 | 3.81 | 3.90 | 3.751 | 3.84 | 8.440M |
| Aug 14, 2026 | 3.70 | 3.755 | 3.65 | 3.74 | 980415.0 |
| Aug 13, 2026 | 3.75 | 3.76 | 3.64 | 3.71 | 1.357M |
| Aug 12, 2026 | 3.70 | 3.74 | 3.615 | 3.72 | 901396.0 |
| Aug 11, 2026 | 3.77 | 3.775 | 3.655 | 3.69 | 804120.0 |
| Aug 10, 2026 | 3.85 | 3.87 | 3.74 | 3.75 | 1.122M |
| Aug 07, 2026 | 3.83 | 3.91 | 3.77 | 3.89 | 1.460M |
| Aug 06, 2026 | 3.76 | 3.815 | 3.685 | 3.77 | 1.042M |
| Aug 05, 2026 | 3.80 | 3.82 | 3.72 | 3.77 | 1.254M |
| Aug 04, 2026 | 3.73 | 3.835 | 3.695 | 3.80 | 2.349M |
| Aug 03, 2026 | 3.63 | 3.725 | 3.544 | 3.71 | 2.262M |
| Jul 31, 2026 | 3.72 | 3.73 | 3.47 | 3.58 | 3.525M |
| Jul 30, 2026 | 3.60 | 3.75 | 3.58 | 3.72 | 1.147M |
| Jul 29, 2026 | 3.69 | 3.76 | 3.59 | 3.62 | 1.113M |
| Jul 28, 2026 | 3.73 | 3.76 | 3.62 | 3.72 | 1.205M |
| Jul 27, 2026 | 3.76 | 3.81 | 3.70 | 3.73 | 589764.0 |
| Jul 24, 2026 | 3.78 | 3.81 | 3.70 | 3.72 | 572862.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Cocrystal Pharma, Inc. | 1.11 |
| CNBX Pharmaceuticals, Inc. | 0.0001 |
| GB Sciences, Inc. | 0.0003 |
| Arvinas, Inc. | 9.17 |
| Definium Therapeutics, Inc. | 40.97 |
Price Related Metrics
| Price to Book Value | 0.9465 |
| Earnings Yield | -31.47% |
| Market Cap | 294.08M |